It has been documented that tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta(2)-agonists (LABAs) and combined administration of a LABA and an inhaled corticosteroid (ICS) reduces the potential for acute effects of LABA on blood-gas tensions. In this study, we have compared the acute effects of tiotropium 18 mu g and salmeterol/fluticasone combination (SFC) 50/250 mu g on arterial blood gases in 20 patients with stable COPD. Each subject was studied on 2 days, separated from one another by at least 4 days. Blood specimens were taken just before the inhalation and at 15, 30, 60, 180 and 360 min after inhalation of each treatment, and spirometry was performed at the same time points. As expected, both treatments significantly improved FEV1 (greatest changes were 0.20 L, 95% CI: 0.13-0.27 at 360 min after tiotropium; and 0.13 L, 95% CI: 0.06-0.19 at 180 min after SFC). The greatest mean changes from baseline in PaO2 were -1.7 (95% CI: -4.0 to 0.6) mmHg, p = 0.134, after tiotropium; -0.8 (95% CI: -2.2 to 0.6) mmHg, after SFC. Both changes were observed after 15 min. Both drugs caused a small decrease in PaCO2 (greater changes: -1.9 (95% CI -3.2 to -0.6) mmHg, p = 0.005 at 60 min after tiotropium; and -2.4 (95% CI: -3.5 to -1.3) mmHg, p = 0.0002 at 180 min after SFC). These results indicate that both tiotropium and SFC are able to induce a significant long-last bronchodilation without affecting arterial blood gases. Moreover, they confirm that the impact of tiotropium on PaO2 is small and without clinical significance and the addition of a LABA to an ICS can reduce the potentially dangerous acute effect of the LABA on blood gases. (C) 2008 Published by Elsevier Ltd.

Ando, F., Ruggeri, P., Girbino, G., Cazzola, M. (2008). Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD, 102(6), 815-818 [10.1016/j.rmed.2008.01.020].

Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD

CAZZOLA, MARIO
2008-01-01

Abstract

It has been documented that tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta(2)-agonists (LABAs) and combined administration of a LABA and an inhaled corticosteroid (ICS) reduces the potential for acute effects of LABA on blood-gas tensions. In this study, we have compared the acute effects of tiotropium 18 mu g and salmeterol/fluticasone combination (SFC) 50/250 mu g on arterial blood gases in 20 patients with stable COPD. Each subject was studied on 2 days, separated from one another by at least 4 days. Blood specimens were taken just before the inhalation and at 15, 30, 60, 180 and 360 min after inhalation of each treatment, and spirometry was performed at the same time points. As expected, both treatments significantly improved FEV1 (greatest changes were 0.20 L, 95% CI: 0.13-0.27 at 360 min after tiotropium; and 0.13 L, 95% CI: 0.06-0.19 at 180 min after SFC). The greatest mean changes from baseline in PaO2 were -1.7 (95% CI: -4.0 to 0.6) mmHg, p = 0.134, after tiotropium; -0.8 (95% CI: -2.2 to 0.6) mmHg, after SFC. Both changes were observed after 15 min. Both drugs caused a small decrease in PaCO2 (greater changes: -1.9 (95% CI -3.2 to -0.6) mmHg, p = 0.005 at 60 min after tiotropium; and -2.4 (95% CI: -3.5 to -1.3) mmHg, p = 0.0002 at 180 min after SFC). These results indicate that both tiotropium and SFC are able to induce a significant long-last bronchodilation without affecting arterial blood gases. Moreover, they confirm that the impact of tiotropium on PaO2 is small and without clinical significance and the addition of a LABA to an ICS can reduce the potentially dangerous acute effect of the LABA on blood gases. (C) 2008 Published by Elsevier Ltd.
2008
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO
English
Con Impact Factor ISI
beta adrenergic receptor stimulating agent; fluticasone propionate plus salmeterol; oxygen; tiotropium bromide; arterial gas; article; blood gas tension; blood sampling; bronchodilatation; chronic obstructive lung disease; clinical article; drug effect; fatty acid desaturation; forced expiratory volume; human; priority journal; spirometry; Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Inflammatory Agents; Bronchodilator Agents; Carbon Dioxide; Cross-Over Studies; Drug Combinations; Forced Expiratory Volume; Humans; Oxygen; Partial Pressure; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives; Vital Capacity
Ando, F., Ruggeri, P., Girbino, G., Cazzola, M. (2008). Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD, 102(6), 815-818 [10.1016/j.rmed.2008.01.020].
Ando, F; Ruggeri, P; Girbino, G; Cazzola, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/42151
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 6
social impact